CLINICAL_TRIALS
trial_result
· 2016-02-24
Clinical Trial Update: A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris [Phase 2]
Summary
Phase 2 trial results for LEO 90100 (cutaneous spray and ointment) in psoriasis vulgaris have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2016-02-24